SCHEMBL7424890

SCHEMBL7424890

CCOC=CC=C(C(=O)OCC)C(=O)OCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 1/20 0.53
NPSR1 Q6W5P4 3/20 0.48
ALDH1A1 P00352 5/20 0.45
GAA P10253 3/20 0.45
CYP2D6 P10635 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
MAPT P10636 4/20 0.39
LMNA P02545 4/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
S1PR4 O95977 1/20 0.39
S1PR1 P21453 1/20 0.39
MAPK1 P28482 1/20 0.39
DHODH Q02127 2/20 0.38
TDP1 Q9NUW8 1/20 0.36
PLIN1 O60240 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13307089 1.00 GLO1 (0.53) GLO1NPSR1ALDH1A1GAACYP2D6
SCHEMBL3379220 0.84 GLO1 (0.53) GLO1NPSR1ALDH1A1GAACYP2D6
SCHEMBL13306415 0.84 GLO1 (0.53) GLO1NPSR1ALDH1A1GAACYP2D6
SCHEMBL15273109 0.80 GLO1 (0.77) GLO1NPSR1ALDH1A1GAACYP2D6
SCHEMBL8252705 0.79 GLO1 (0.40) GLO1NPSR1ALDH1A1GAACYP2D6
SCHEMBL14279176 0.79 GLO1 (0.48) GLO1NPSR1ALDH1A1GAACYP2D6
SCHEMBL19723129 0.79 GLO1 (0.48) GLO1NPSR1ALDH1A1GAACYP2D6
SCHEMBL5759198 0.79 GLO1 (0.33) GLO1
SCHEMBL5759201 0.79 GLO1 (0.33) GLO1
SCHEMBL14279206 0.79 GLO1 (0.57) GLO1NPSR1ALDH1A1GAACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067356-B1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2018-07-04 EP disclosed
US-9586967-B2 Pyrrolo pyrimidine derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-03-07 US disclosed
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-09-15 US disclosed
EP-3067356-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2016-09-14 EP disclosed
WO-2000061631-A1 MODIFIED PENTAPEPTIDE ANTAGONISTS OF THE ATRIAL NATRIURETIC PEPTIDE CLEARANCE RECEPTOR ASTRAZENECA AB (SE) 2000-10-19 WO disclosed
US-4104273-A Derivatives of 3-cyano-pyrid-2-ones ROHM AND HAAS COMPANY (US) 1978-08-01 US disclosed
US-4028084-A Derivatives of 3-carboxy pyrid-2-ones ROHM AND HAAS COMPANY (US) 1977-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE AXL, FLT3, TYRO3 GLO1 2894/4885NPSR1 2451/4885ALDH1A1 3360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.